A slight majority of LPs (56%) are seeking to improve their attractiveness to GPs as co-investment partners, according to Coller Capital's Global Private Equity Barometer for winter 2021-22.
Secondary buyout sees San-Francisco-based GP pre-empt auction for Italian generic drugmaker
GP makes series of promotions and appointments following GBP 2.5bn fundraising earlier this year
Enact III is more than three times the size of its predecessor fund, which closed on GBP 30m in 2019
Andre Retterath and Paul Klemm are existing team members, while Vincenzo Narciso joins from Px3 Partners